Wendy Miller

Purdue Pharma (Canada)

Papers

1

Total Citations

18

H-Index

1

About

Dr. Wendy Miller is a pioneering biochemist whose work has significantly advanced high-throughput screening methodologies. Her primary research focuses on the development of innovative assay technologies for ligand-binding studies, particularly in drug discovery. Her most notable contribution, the "Development of a Fluorescent Ligand-Binding Assay Using the AcroWell Filter Plate" (2000), introduced a robust, miniaturized platform that streamlined the detection of receptor-ligand interactions. This seminal paper, with 18 citations, laid the groundwork for more efficient and cost-effective screening processes, enabling researchers to rapidly identify potential therapeutic compounds. Dr. Miller's work is distinguished by its practical impact on laboratory automation and assay sensitivity, making her a key figure in the evolution of modern biochemical analysis. Her achievements reflect a deep commitment to bridging fundamental biochemistry with translational applications, inspiring students and researchers to explore the intersection of technology and molecular biology.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Development of a Fluorescent Ligand-Binding Assay Using the AcroWell Filter Plate
18 citations · 2000
📈 Most Prolific Year: 2000 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Purdue Pharma (Canada)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago